KEI 10 March 2017 Comments on Army Exclusive License on Zika Virus Vaccine Patents to Sanofi
On March 10, 2017, KEI filed our 3rd set of comments with the U.S. Army Medical Research and Material Command (USAMRMC) on their proposed grant of an exclusive license on Zika virus vaccine patents to the French pharmaceutical company Sanofi.